Randomized trial demonstrates improved cardiac performance in Chagas disease, suggesting new treatment avenues.
-infection and their biological consequences on parasite/host interactions. The therapeutic effects of the 1D11 antibody are promising and suggest a new possibility to treat cardiac fibrosis in the chronic phase of Chagas' heart disease by TGF-β neutralization.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: